.jpg)
- Second Busiest Month Ever for European Cash Markets: Vol. Up 61.5% y-o-y
- Busiest Month Ever for European Derivatives Vol., Up 34.5% y-o-y, and New Annual Volume Record with 799 Million Contracts Already Traded This Year
- NYSE Group: Handled Equities Vol. Up 14.4% y-t-d, Handled ETF Vol. Up 70.5%
- NYSE Arca Options: New All-Time Records in Volume and Share of Trading
NYSE Euronext (NYSE Euronext: NYX) reported strong transaction volumes in U.S. and European trading operations for October 2007, highlighted by record activity on Liffe and NYSE Arca Options.
Average daily volumes of 2.7 billion shares handled(1) on NYSE Group in October 2007 resulted in year-over-year gains of 5.9% while 30.4 million transactions(2) were recorded on Euronext cash markets during the month, up 61.5% year-over-year. Liffe registered its busiest October ever, with trading up 34.5% from a year-ago, and topping last year's volume recorded for the full year. Total volume for equity options trading on NYSE Arca Options reached record levels increasing 67.8% year-over-year. Average daily volume in October improved by 110.0% year-over-year, which included October's new record of 1.66 million contracts traded.
NYSE Euronext, with six cash equities and six derivatives exchanges, is the leading and most diversified global exchange group.
Cash Products
Euronext
-- Euronext's cash markets registered their second busiest month
ever with 30.4 million transactions completed in October 2007,
up 61.5% from the same month last year.
-- Since the beginning of the year, more than 266 million cash
transactions were registered on Euronext, up 46.2% from the
same period last year, representing a record average daily
volume of over 1.2 million transactions.
-- Euronext reported 29.2 million equities transactions in
October 2007, up 62.6% year-on-year. This brought the
year-to-date total number of transactions to 255 million, up
46.8% versus the same period last year.
-- Year-on-year transactions on Euronext were up 196.7% for ETFs
and up 34.7% for Structured Products, which includes warrants
and certificates.
NYSE Group
-- NYSE Group's exchanges reported 2.7 billion shares handled per
day in October, up 5.9% year-over-year. Average daily handled
volume in 2007 is up 14.4% year-to-date.
-- NYSE Group's operations in NYSE-listed securities reported 2.0
billion shares handled per day, up 7.9% from the same month
last year with total volume in 2007 up 18.6% year-to-date.
-- NYSE Group's operations in ETF trading reported 289 million
shares handled daily, up 70.5% from the same period last year
with total volume in 2007 up 58.8% year-to-date. NYSE Arca is
the first electronic stock exchange to offer investors the
benefits and stability of a dedicated liquidity provider in
the form of a Lead Market Maker for each primary listed ETF,
with listings that represent 67% of the total assets under
management and 42% of ETF trading volume for all U.S. ETFs
year-to-date.
Derivatives Products
Liffe
-- Liffe, NYSE Euronext's leading futures and options business,
had its busiest October ever, with more than 74 million
futures and option contracts traded, up 34.5% year-on-year.
-- In total, Liffe has traded a record number of contracts for
the fourth consecutive year. 799 million futures and options
contracts have already been traded in 2007, beating the 2006
annual record volume of 730 million contracts. Total volume
year-to-date (January-end October) is up 29.2% compared to
2006.
-- Year-to-date volumes have grown across the entire product
range. Interest rate products have traded 441 million
contracts year-to-date, up 26.9% on 2006. Equity products have
traded 347 million contracts so far this year, up 32.4% on
2006. Commodity products have traded 10.5 million contracts,
up 28.9% on 2006.
-- Bclear has its busiest year ever processing over 96 million
contracts since the beginning of the year compared to the 51
million traded for full year 2006. Year-on-year Bclear is up
165.2% on 2006.
-- Universal Stock Futures traded record volumes of 58 million
since the beginning of the year compared to a total annual
volume of 29 million in 2006.
NYSE Arca Options
-- NYSE Arca reported a new all-time record of 1.66 million
equity options contracts executed daily on average in October,
up 110% from the same month last year. Over 258 million equity
options contracts have traded since the beginning of the year,
up 67.8% year-to-date.
-- With 38.2 million total contracts traded in October, a 21.5%
increase from the previous record of 31.4 million contracts
set in August 2007, NYSE Arca Options also achieved a new
record in overall share of trading, capturing 14.2% of all
equity options contracts traded, a 4.2% increase
year-over-year.
-- In October, 17.6 million contracts were traded on NYSE Arca
Options in the newly-expanded SEC options penny pilot, with
15.8 million, or 90% traded electronically. Share of trading
in the 35 penny pilot issues also set a record in October at
17.0% of industry volumes, ranking NYSE Arca third among all
U.S. options exchanges.
Listings
Euronext
-- Eleven IPOs were added on Euronext's markets in October 2007,
with EUR 3.4/$4.9 billion raised.
-- This brings the total number of IPOs on Euronext since the
beginning of the year to a record 118, as compared to 106
during the same period in 2006, with EUR 9.3/$13.4 billion
raised in connection with new listings.
-- Additionally, four new ETFs were listed on NextTrack in
October, bringing the total number of new ETF listings since
the beginning of the year to 61.
NYSE Group
-- October produced a total of 33 new listings on NYSE Group
markets, including 16 operating companies on the NYSE, 2
operating companies on NYSE Arca, and 15 Exchange Traded
products. Of the 15 Exchange Traded products, 6 were Exchange
Traded Funds and 9 were Exchange Traded Notes.
-- There were 11 IPOs in October, including 4 U.S. domestic
operating companies and 5 non-US companies, as well as 2 IPOs
on NYSE Arca.
-- The 4 U.S. domestic operating companies that conducted IPOs on
NYSE Group markets in October raised a total of EUR 1.0/$1.5
billion in IPO proceeds in connection with listing, and 5
non-U.S. companies raised EUR 605.6/$876.2 million in
connection with listing. Including offerings on NYSE Arca and
Exchange Traded products, a total of EUR 1.8/$2.6 billion in
IPO proceeds was raised in connection with listing on NYSE
Group markets in October 2007.
-- Separate, and in addition to the 33 new listings already
highlighted, 3 new structured products joined the NYSE in
October 2007.
Note:
Based on third-quarter 2007 non-GAAP net revenues (excluding activity assessment fees, and liquidity payments, routing and clearing fees) NYSE Euronext revenues from its primary business activities are represented below as a percentage of total net revenues:
-- Derivatives trading accounts for 25%
-- European cash trading accounts for 18%
-- U.S. cash trading accounts for 12%
-- Market data accounts for 13%
-- Listing accounts for 12%
On Oct. 31, 2007: EUR 1 = $1.4468
Appendix: NYSE Euronext Markets Tables
About NYSE Euronext
NYSE Euronext, a holding company created by the combination of NYSE Group, Inc. and Euronext N.V., commenced trading on April 4, 2007. NYSE Euronext (NYSE Euronext: NYX) operates the world's largest and most liquid exchange group and offers the most diverse array of financial products and services. NYSE Euronext, which brings together six cash equities exchanges in five countries and six derivatives exchanges in six countries, is a world leader for listings, trading in cash equities, equity and interest rate derivatives, bonds and the distribution of market data. Representing a combined $30.3 trillion/EUR 21.3 trillion total market capitalization of listed companies and average daily trading value of approximately $139 billion/EUR 103 billion (as of September 30, 2007), NYSE Euronext seeks to provide the highest standards of market quality and integrity, innovative products and services to investors, issuers, and all users of its markets.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2006 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on June 6, 2007 under No. R.07-0089), 2006 Annual Report on Form 10-K, as amended, and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
(1) Handled shares represent the total number of shares of equity securities internally matched on the NYSE Group's exchanges or routed to and executed at an external market center.
(2) Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.
NYSE Euronext
Monthly Volume Summary - Cash Products
----------------------------------------------------------------------
Average Daily Total Volume Total Volume
Volume
--------------------------------------- --------------
(Unaudited) Oct- Oct- % Chg Oct-07 Oct-06 % Chg YTD % Chg
07 06 2007 vs.
YTD
2006
----- ----- ------ ------ ------ ------ ------- ------
Number of
Trading Days -
European
Markets 23 22 23 22 214
Number of
Trading Days -
U.S. Markets 23 22 23 22 210
European Cash
Products
(trades in
thousands) 1,322 856 54.5% 30,395 18,823 61.5% 266,285 46.2%
Equities 1,268 815 55.5% 29,162 17,938 62.6% 255,095 46.8%
Exchange-Traded
Funds 8 3 183.8% 180 61 196.7% 1,270 129.6%
Structured
Products 40 31 28.8% 911 676 34.7% 8,524 32.5%
Bonds 6 7 -8.1% 142 148 -4.0% 1,397 1.1%
U.S. Cash
Products
(shares in
millions)
NYSE Listed
Issues (1)
NYSE Group
Handled Volume
(2) 2,048 1,898 7.9% 47,107 41,763 12.8% 466,324 18.6%
NYSE Group
Matched Volume
(3) 1,841 1,853 -0.6% 42,343 40,755 3.9% 432,588 12.4%
NYSE Group TRF
Volume (4) 134 - - 3,092 - - 9,845 -
Total NYSE
Listed
Consolidated
Volume 3,394 2,677 26.8% 78,067 58,892 32.6% 699,573 32.9%
NYSE Group Share of
Total Consolidated
Volume
Handled Volume
(2) 60.3% 70.9% 60.3% 70.9% 66.7%
Matched Volume
(3) 54.2% 69.2% 54.2% 69.2% 61.8%
TRF Volume (4) 4.0% - 4.0% - 1.4%
NYSE Arca &
Amex Listed
Issues
NYSE Group
Handled Volume
(2) 209 127 65.0% 4,802 2,783 72.5% 40,805 52.8%
NYSE Group
Matched Volume
(3) 177 110 60.4% 4,062 2,422 67.7% 36,883 59.3%
NYSE Group TRF
Volume (4) 39 - - 890 - - 3,574 -
Total NYSE Arca
& Amex Listed
Consolidated
Volume 628 335 87.4% 14,454 7,375 96.0% 114,606 52.3%
NYSE Group Share of
Total Consolidated
Volume
Handled Volume
(2) 33.2% 37.7% 33.2% 37.7% 35.6%
Matched Volume
(3) 28.1% 32.8% 28.1% 32.8% 32.2%
TRF Volume (4) 6.2% - 6.2% - 3.1%
Nasdaq Listed
Issues
NYSE Group
Handled Volume
(2) 423 507 -16.5% 9,734 11,150 -12.7% 93,335 -11.3%
NYSE Group
Matched Volume
(3) 339 408 -16.8% 7,803 8,975 -13.1% 76,062 -11.3%
NYSE Group TRF
Volume (4) 151 - - 3,475 - - 19,309 -
Total Nasdaq
Listed
Consolidated
Volume 2,186 2,030 7.7% 50,285 44,653 12.6% 456,472 6.6%
NYSE Group Share of
Total Consolidated
Volume
Handled Volume
(2) 19.4% 25.0% 19.4% 25.0% 20.4%
Matched Volume
(3) 15.5% 20.1% 15.5% 20.1% 16.7%
TRF Volume (4) 6.9% - 6.9% - 4.2%
Exchange-Traded
Funds (1,5)
NYSE Group
Handled Volume
(2) 289 170 70.5% 6,654 3,734 78.2% 57,720 58.8%
NYSE Group
Matched Volume
(3) 255 153 66.8% 5,860 3,361 74.4% 51,442 57.5%
NYSE Group TRF
Volume (4) 54 - - 1,237 - - 5,110 -
Total ETF
Consolidated
Volume 777 394 97.1% 17,878 8,675 106.1% 138,363 63.8%
NYSE Group Share of
Total Consolidated
Volume
Handled Volume
(2) 37.2% 43.0% 37.2% 43.0% 41.7%
Matched Volume
(3) 32.8% 38.7% 32.8% 38.7% 37.2%
TRF Volume (4) 6.9% - 6.9% - 3.7%
NYSE Euronext
----------------------------------------------------------------------
Monthly Volume Summary - Derivatives Products
----------------------------------------------------------------------
Average Daily Total Volume Total Volume
Volume
------------------- ---------------------- ----------------
(Unaudited;Oct-07 Oct- % Chg Oct-07 Oct-06 % Chg YTD 2007 % Chg
contracts 06 vs.
in YTD
thousands) 2006
------ ----- ------ ------- ------- ------ --------- ------
Number of
Trading
Days -
European
Markets 23 22 23 22 214
Number of
Trading
Days -
U.S.
Markets 23 22 23 22 210
European
Deri-
vatives
Products 3,243 2,520 28.7% 74,593 55,447 34.5% 799,021 29.2%
Total
Interest
Rate
Products 1,865 1,431 30.3% 42,897 31,480 36.3% 441,562 26.9%
Short Term
Interest
Rate
Products 1,772 1,356 30.7% 40,752 29,821 36.7% 417,519 26.8%
Medium and
Long Term
Interest
Rate
Products 93 75 23.7% 2,145 1,659 29.3% 24,043 28.1%
Total
Equity
Products
(6) 1,324 1,042 27.0% 30,459 22,933 32.8% 346,550 32.4%
Individual
Equity
Products 771 612 26.0% 17,731 13,455 31.8% 217,195 35.7%
Equity
Index
Products 553 431 28.5% 12,728 9,478 34.3% 129,355 27.0%
of which
Bclear 308 121 153.6% 7,076 2,668 165.2% 96,855 114.2%
Individual
Equity
Products 196 67 191.1% 4,508 1,481 204.3% 79,868 138.9%
Equity
Index
Products 112 54 107.0% 2,568 1,187 116.4% 16,988 44.1%
Commodity
Products 52 36 42.8% 1,186 794 49.3% 10,501 28.9%
Currency
Products 2 11 -79.3% 52 239 -78.4% 407 -36.7%
U.S.
Deriva-
tives
Products -
Equity
Options
(7)
NYSE Arca
Options
Contracts 1,660 791 109.9% 38,189 17,399 119.5% 258,647 67.8%
Total
Conso-
lidated
Options
Contracts 11,664 7,943 46.8% 268,276 174,752 53.5% 2,090,669 37.5%
NYSE Group
Share of
Total 14.2% 10.0% 14.2% 10.0% 12.4% 2.3%
(1) Includes all volume executed in NYSE Group crossing sessions.
(2) Represents the total number of shares of equity securities and
ETFs internally matched on the NYSE Group's exchanges or routed to
and executed at an external market center. NYSE Arca routing includes
odd-lots.
(3) Represents the total number of shares of equity securities and
ETFs executed on the NYSE Group's exchanges.
(4) Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility
(TRF).
(5) Data included in previously identified categories.
(6)Includes all trading activities for Bclear, Euronext.liffe's
clearing service for wholesale equity derivatives.
(7) Includes trading in U.S. equity options contracts, not equity-
index options.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading
which is double counted to include both buys and sells.
